Revance The (RVNC)

NASDAQ
14.60
-0.20(-1.35%)
After Hours
14.50
-0.10(-0.68%)
- Real-time Data
  • Volume:
    707,658
  • Bid/Ask:
    14.50/14.90
  • Day's Range:
    14.30 - 14.82

RVNC Overview

Prev. Close
14.8
Day's Range
14.3-14.82
Revenue
62.98M
Open
14.82
52 wk Range
12.34-33.83
EPS
-4.48
Volume
707,658
Market Cap
1.05B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,289,842
P/E Ratio
-
Beta
0.82
1-Year Change
-39.07%
Shares Outstanding
71,794,852
Next Earnings Date
Mar 02, 2022
What is your sentiment on Revance The?
or
Market is currently closed. Voting is open during market hours.

Revance The Company Profile

Employees
470

Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection (DAXI), which has completed phase III clinical trials for the treatment of glabellar (frown) lines and cervical dystonia; is in phase II clinical trials to treat upper facial lines, moderate or severe dynamic forehead lines, and moderate or severe lateral canthal lines; and has completed Phase II clinical trials for the treatment of adult upper limb spasticity and plantar fasciitis. It is also developing DAXI in preclinical trial for the treatment of migraine, as well as a topical program for various indications; and OnabotulinumtoxinA, a biosimilar to BOTOX. The company has a collaboration and license agreement with Viatris Inc. for the development and regulatory approval of a biosimilar to BOTOX. The company was formerly known as Essentia Biosystems, Inc. and changed its name to Revance Therapeutics, Inc. in April 2005. Revance Therapeutics, Inc. was incorporated in 1999 and is headquartered in Newark, California.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralBuyStrong BuyNeutralStrong Sell
Technical IndicatorsStrong SellBuyStrong BuyBuyStrong Sell
SummarySellBuyStrong BuyNeutralStrong Sell
  • do you have any guesses?Cost 15.24
    0
    • RVNC (P) 0.00000000 15.78000000
      0
      • Bought loads at 13,89 average
        0
        • Sold at 15,20
          0
      • Classic bulish flag.
        0
        • Lovely bulish flag!
          0
      • $RVNC has all 5 analyst saying “BUY” with an ave 12 month target price of $40 which is 127% ROI at its closing price of $12.71
        1
        Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
        Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.